Vous êtes ici: Home > Therapeutics (ancienne) > Effects of Smoked Cannabis and Oral delta-9-Tetrahydrocannabinol on Nausea and Emesis After Cancer Chemotherapy: A Review of State Clinical Trials

J Cannabis Ther 2001(1):026-56

Cancer Chemotherapy

Effects of Smoked Cannabis and Oral delta-9-Tetrahydrocannabinol on Nausea and Emesis After Cancer Chemotherapy: A Review of State Clinical Trials

Author
R.E. Musty, R. Rossi

Abstract
Background. In 1999 the Institute of Medicine (IOM) issued a report entitled Marijuana and Medicine (Joy, Watson and Benson, 1999). It recommended the development of cannabinoid drug delivery systems which might be effective for nausea, vomiting and AIDS wasting syndrome, among other chronic disorders. The report went on to recognize that patients should be allowed to smoke marijuana if they failed to achieve relief from approved symptoms that could be relieved by cannabinoid drugs with rapid onset. Recommended criteria of the report included: access to marijuana within 24 hours of submission by a physician, supervision that allows for assessment of treatment effectiveness, and an oversight strategy comparable to an institutional review board. In this context a review of previously unpublished state-run clinical trials with Cannabis sativa (marijuana and/ or delta 9-tetrahydrocannabinol capsules) to test efficacy in reducing nausea and vomiting following cancer chemotherapy is warranted. The impetus for these studies came from individual state legislatures responding to constituents' claims that smoking marijuana reduced or blocked nausea and vomiting.

Methods. Technical reports were obtained from 6 states which had conducted clinical trials. Each protocol was examined for the procedure used, the experimental design of the clinical trial and the results obtained. Data were available on 748 patients who smoked marijuana prior to and/or after cancer chemotherapy and 345 patients who used the oral THC capsule.

Results. Patients who smoked marijuana experienced 70-100% relief from nausea and vomiting, while those who used the THC capsule experienced 76-88% relief.

Conclusions. On the basis of these studies, it appears that smoked marijuana can be a very successful treatment for nausea and vomiting following cancer chemotherapy. The development of smokeless inhalation devices could certainly reduce the potential harm from smoking marijuana.


Keywords
Cannabis, cannabinoid, marijuana, cancer, chemotherapy, nausea, vomiting, tetrahydrocannabinol

Texte intégral au format PDF ]

Events Online 2020

Toutes les informations sur les événements en ligne de l'IACM, y compris les vidéos gratuites des webinaires sous-titrées en français, sont disponibles ici.

IACM Conference 2021

La 12e conférence de l'IACM sur les cannabinoïdes en médecine se tiendra en ligne du 14 au 16 octobre 2021. L'inscription est gratuite.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.